In Stock
CAS: 2381089-83-2Retatrutide
Triple-Agonist GIP/GLP-1/Glucagon Receptor Peptide
Retatrutide (LY3437943) is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. Biolyn supplies research-grade and API-grade Retatrutide to qualified research institutions, pharmaceutical developers, and B2B formulation partners across Europe and globally.
Technical Profile
A 39-amino acid synthetic peptide with a C20 fatty diacid moiety linked via a linker to Lys13. Produced via solid-phase peptide synthesis (SPPS) with stringent purification protocols ensuring >99% chromatographic purity.
CAS Number2381089-83-2
Molecular Weight4,113.58 g/mol
Molecular FormulaC190H302N56O53S2
Purity>99% (HPLC)
FormLyophilized Powder
Storage-20C, desiccated, protected from light
Applications
Metabolic disease researchGLP-1/GIP/Glucagon receptor binding studiesPreclinical pharmacologyAPI for pharmaceutical formulation (B2B)Investigational compound development